SECONDARY HYPEROXALURIA

Clinical trials for SECONDARY HYPEROXALURIA explained in plain language.

Never miss a new study

Get alerted when new SECONDARY HYPEROXALURIA trials appear

Sign up with your email to follow new studies for SECONDARY HYPEROXALURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a phosphate binder curb kidney stone risk?

Disease control Completed

This trial tests whether lanthanum carbonate, a drug typically used to bind phosphate, can also reduce oxalate levels in urine. People with secondary hyperoxaluria and a history of kidney stones take the drug with meals for 28 days, with the dose increasing after two weeks. The g…

Matched conditions: SECONDARY HYPEROXALURIA

Phase: PHASE3 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC

SECONDARY HYPEROXALURIA

Get alerted when new SECONDARY HYPEROXALURIA trials appear

Can a phosphate binder curb kidney stone risk?